102389-53-7

Upstream product

• 1571-08-0 methyl 4-formylbenzoate 
• 619-44-3 methyl 4-iodobenzoate 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 69251-24-7 [1-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-ethyl]-triphenylphosphonium bromide 
• 14295-52-4 4-(diethyoxyphosphorylmethyl)benzoic acid methyl ester 
• 17610-21-8 1-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphth-2-yl)ethanone 
• 71-43-2 benzene 
• 6683-46-1 1,1,4,4-Tetramethyl-1,2,3,4-tetrahydro-naphthalene 
• 6223-78-5 2,5-dichloro-2,5-dimethyl hexane 

Downstream Products

• 119436-68-9 4-[3-Methyl-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-oxiranyl]-benzoic acid methyl ester 
• 119436-71-4 4-[(1S,2S)-1,2-Dihydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-propyl]-benzoic acid methyl ester 
• 71441-28-6 TTNPB 
• 119436-74-7 Methyl 4-<2,2,5-trimethyl-5-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-4-yl>benzoate 
• 119436-13-4 4-<2,2,5-Trimethyl-5-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1,3-dioxolan-4-yl>benzoic acid 
• 119436-10-1 4-[(1S,2S)-1,2-Dihydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-propyl]-benzoic acid 
• 119436-07-6 4-[3-Methyl-3-(5,5,8,8-tetra-methyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-oxiranyl]-benzoic acid 

Relevant academic research and scientific papers

A method for synthesizing substituted diphenyl derivatives

The invention relates to a synthesis method of a compound shown in Formula (I). A compound shown in Formula (III) is prepared via reaction of a compound shown in Formula (II) with a phase transfer catalyst, and the compound shown in Formula (I) is prepared via direct hydrolysis of the compound shown in Formula (III).

18-20 MEMBER BI-POLYCYCLIC COMPOUNDS

The invention relates to 18-20 member bi-polycyclic compounds, methods of making these compounds, and methods of using them in treating hyperproliferative disorders (e.g., cancer) and non-malignant tumors; promoting muscle formation; inhibiting muscle degeneration or the loss of muscle mass or muscle function; and myofibers ex vivo.

Retinoid compounds and their use

The invention relates to retinoid compounds of the formula (I): wherein V is a hydrophobic group;W is a non-polyenic linker; andX is a polar group comprising a hydrogen bond donor; or a salt thereof, and to the use of such compounds in the control of cell differentiation.

Strong Bicyclic Guanidine Base-promoted Wittig and Horner-Wadsworth-Emmons Reactions

formula presented A convenient procedure to effect the Wittig and Horner-Wadsworth-Emmons reactions employs guanidine TBD and MTBD as base-promoters; mild reaction conditions, high efficiency, and facile isolation of the final products make the present methodology, at least in some cases, a practical alternative to known procedures.